Treatment of Chronic Renal Failure With Adipose Tissue-derived Mesenchymal Stem Cells
Status:
Unknown status
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
To investigate the biological characteristics of adipose tissue-derived mesenchymal stem
cells(AMSCs) and its treatment effects on chronic renal failure.
Phase:
N/A
Details
Lead Sponsor:
The Affiliated Hospital of Xuzhou Medical University